Vol.2 No.2 {us Taiwan Geriatr Gerontol
|
|
- Todd Mosley
- 5 years ago
- Views:
Transcription
1 j Vol.2 No.2 {us Taiwan Geriatr Gerontol f {us 1 n 2 h éè r f Èu (LDL) Èu v q Ë f} vf Èu Ì{ s 46 mg dl 131 mg dl f (HDL) Èu x ˆ šá j f ( ) 1.3% % Ç f jë {f s š ï j Ç ï f {f r Ëf k } lr r u j (2) {xj Èuf u uf x ˆ 1 u{u { k 2 é é l ri n ri é é l 806 yž so chungyu.anchen@msa.hinet.net 63
2 u j f 2 2 i f k x ˆ z { Ë 1960 sg [1] i tf Èu u Ö } f (T4) (TSH) u Ë f Èu gh (premyxedema) k sr è è iè f šá x ˆ k ~ ru } i éè f Èu (LDL) è r u u(tg) (intermediate density lipoprotein, IDL) apoprotein A-1 apoprotein B Ë ~u 295 Frederickson vð f k [2]:Type IIa ( Èu f ) 56 % Type IIb ( Èuf u uf ) 34 % Type IV ( u uf ) 1.5% 8.5 % è{ f (HDL) Ë Ú g Ëv HDL-2 }HDL-3 Ë T4 Ç [3] f Ç ï (a) Ë Ë z {[4] Ë z l [5] (meta-analysis) 19 ~ Ú f Èu [6] zó f Èu 310 mg dl Ë z Ì { 46 mg dl nr 310 mg dl {ès 131 mg dl èëidl }( x Ç ) IDL Ë {[7] ( ) q Èuf q LDLË f} (receptors) r LDL Œ k (catabolism) r LDL Èu Ëf è Ç ËLDL } [8] è r LDL (upregulation) ÇLDL ÖÇ èð j Ë ~ 64
3 Vol.2 No.2 {us Taiwan Geriatr Gerontol ÖÇÐ[genotype(-/-)] Ë z genotype (+/+){ f Èu èsç [9] v ~ f È u q 1. LDL Œ(oxidation) Ë á v f LDL Èu {[10] 2.Ë ˆ k Èu ru u u èr u uf Ç i (lipoprotein lipase) { u u (chylomicron remnants)ë Ë z g r {[11] ( ) t x ˆ { x ˆ á š j š f á r ä r u å r x Ç } f Èu fä Ë x Ç [31] Ë ~ ~ f Èu þí f (antithyroglobulin) (antithyroid microsomal antibodies) f q (a) Ç j Ë x Ç [12] ÉWhickhamË r 2,800 Ë 20 rp z x ˆ { { t ~ x { [13] ( ) f f f } 1,210 f Èu é 200 mg dl v 1.3% 11.2% [14] Ë ~248 f v 2.8% 4.4% [15] Ç Èuf u uf jë s {f s š ï j Ç f {f è r t f 65
4 u j f 2 2 f l ïë "broad beta" disease (type III) f r f IDL Ë Èu f (ÇLDL {) r Èu Ë u uf r u u éè f f Èu LDL (a) [7,16] Ë Ç [17,18]: Ì { Èu 9 15 mg dl LDL 11 mg dl Ë Èuf ï Ë ~ LDLËr { 36 mg dl p 0.01 [19] èëidl } { (a) f HPL Ë [16] Ë Ìá [21] Ç r r Ëf k } lr î f Èu LDL HDL apoprotein-b [22] u { á i (lipolysis)á è r f u Ë ~ (a) Ë z á [22] j f ( ) 1.3% % Ç f j Ë {f s š ï j Ç ï f {f 1. Bastenie PA, Vanhaelst L, Neve P: Coronary-artery disease in hypothyroidism. Lancet 1967; 2: O'Brien T, Dinneen SF, O'Brien PC, et al: Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993; 68: Verdugo C, Perrot G, Ponsin G, et al: Time-course of alterations of high density lipoproteins HDL. during thyroxine administration to 66
5 Vol.2 No.2 {us Taiwan Geriatr Gerontol hypothyroid women. Eur J Clin Invest 1987; 17: Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M: Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 2000; 10: Klausen IC, Nielsen FE, Hegedus L, et al. Treatment of hypothyroidism reduces low density lipoproteins but not lipoprotein a. Metabolism 1992; 41: Tanis BC, Westendorp RGJ, Smelt HM: Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hyperthyroidism: A reanalysis of intervention studies. Clin Endocrinol 1996; 44: Ito M, Takamatsu J, Matsuo T, et al: Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinol 2003; 58: Hoogerbrugge N, Jansen H, Staels B, et al: Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats. Metabolism 1996; 45: Wiseman SA, Powell JT, Humphries SE, et al: The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab 1993; 77: Costantini F, Pierdomenico SD, De Cesare D, et al: Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998; 18: Weintraub M, Grosskopf I, Trostanesky Y, et al: Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism. J Clin Endocrinol Metab 1999; 84: Lotz H, Salabe GB: Lipoprotein (a) increase associated with thyroid autoimmunity. Eur J Endocrinol 1997; 136: Vanderpump MPJ, Tunbridge WMG, French JM, et al: The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study in an English community. Thyroid 1996; 6: Bruckert E, De Gennes JL, Dairou F, Turpin G: Frequency of hypothyroidism in a population of hyperlipidemic subjects. Presse Med 1993; 22: Tsimihodimos V, Bairaktari E, Tzallas C, et al: The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. Thyroid 1999; 9: Danese MD, Ladenson PW, Meinert 67
6 u j f 2 2 CL, Powe NR: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000; 85: Caraccio N, Ferrannini E, Monzani F: Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002; 87: Meier C, Staub JJ, Roth CB, et al: TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metabolism 2001; 86: Michalopoulou G, Alevizaki M, Piperingos G, et al: High serum cholesterol levels in persons with 'high-normal' TSH levels: Should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: Ganotakis ES, Mandalaki K, Tampakaki M, et al: Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy. Angiology 2003; 54: Ito M, Takamatsu J, Sasaki I, et al: Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. Am J Med 2004; 117: Hoppichler F, Sandholzer C, Moncayo R, et al: Thyroid hormone reduces lipoprotein a plasma levels. Atherosclerosis 1995; 115:
7 [Review Article] Lipid Profile Deviation in Thyroid Disorders Chung-Yuan Chen 1, Chin-I Lin 2 Abstract Many hypothyroid patients have higher serum levels of lipid profile, i.e. total cholesterol and low-density-lipoprotein (LDL) cholesterol. The primary mechanism of accumulation of LDL cholesterol in hypercholesterolemia in hypothyroidism is caused by reduced number of cell surface receptors for LDL or decreased catabolism of LDL. With Thyroxine (T4) supplement, the serum total cholesterol levels in patients with overt hypothyroidism shows a decrease distribution from 46 mg/dl to 131 mg/dl. With respect to serum high-density-lipoprotein (HDL) cholesterol concentrations, higher, normative or lower levels have been reported among different studies. And it still remains uncertain whether patients with hypothyroidism are at a greater risk of developing coronary heart disease. The prevalence of hypothyroidism (including overt and subclinical hypothyroidism) in patients with hyperlipidemia ranges from 1.3% to 11.2%. It is therefore suggested that patients with hyperlipidemia should be screened on their hypothyroidism before they are administered with a specific lipid-lowering medication. If hypothyroidism is present, the patient should be treated with T4 for three to four months. If the serum lipid concentrations are not then normal, specific lipid-lowering therapy may be considered. Patients with hyperthyroidism tend to be reported changes in lipid metabolism generally opposite to those for hypothyroidism. (Taiwan Geriatr Gerontol 2006;2(2):63-69) Key words: hypothyroidism, hypercholesterolemia, hypertriglyceridemia, coronary heart disease, anti-thyroid antibody 1 Department of Endocrine and Metabolism, Kaohsiung Municipal Min-Shen Hospital; 2 Department of Nursing, Tajen University Correspondence: Chin-I Lin Address: chungyu.anchen@msa.hinet.net 69
Original article : Correlation of Lipid level in Thyroid Disorder Patients: A Case Control Study
Original article : Correlation of Lipid level in Thyroid Disorder Patients: A Case Control Study Dr. Arohi Kumar Associate Professor, Department of General Medicine, Narayan Medical College & Hospital,
More informationX/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society
0021-972X/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Changes in Plasma Low-Density Lipoprotein (LDL)- and High-Density
More informationSubclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia?
ISPUB.COM The Internet Journal of Advanced Nursing Practice Volume 5 Number 1 Subclinical Hypothyroidism In Women: Will Screening And Early Detection Reduce Hyperlipidemia? A Olson Citation A Olson. Subclinical
More informationJournal of Internal Medicine 2006; 260: doi: /j x
Journal of Internal Medicine 2006; 260: 53 61 doi:10.1111/j.1365-2796.2006.01652.x Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid
More informationInternet Journal of Medical Update
Internet Journal of Medical Update 2012 July;7(2):3-8 Internet Journal of Medical Update Journal home page: http://www.akspublication.com/ijmu Original Work Association between different degrees of hypothyroidism
More informationJournal of Clinical and Biomedical Sciences. Serum Lipoprotein (a) and lipid profile in Hypothyroidism.
235 Journal of Clinical and Biomedical Sciences Journal homepage: www.jcbsonline.ac.in Clinical Investigation Serum Lipoprotein (a) and lipid profile in Hypothyroidism. Shilpashree M K 1 *, Ravi B V 2,
More informationASSOCIATION BETWEEN BODY MASS INDEX, LIPID PEROXIDATION AND CORONARY LIPID RISK FACTORS IN HYPOTHYROID SUBJECTS
ASSOCIATION BETWEEN BODY MASS INDEX, LIPID PEROXIDATION AND CORONARY LIPID RISK FACTORS IN HYPOTHYROID SUBJECTS V Shanmugapriya, PK Mohanty, D Anil Kumar Department of Biochemistry, Vinayaka Missions Medical
More informationAmerican Thyroid Association Guidelines for Detection of Thyroid Dysfunction
American Thyroid Association Guidelines for Detection of Thyroid Dysfunction Paul W. Ladenson, MD; Peter A. Singer, MD; Kenneth B. Ain, MD; Nandalal Bagchi, MD, PhD; S. Thomas Bigos, MD; Elliot G. Levy,
More informationHyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi
Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia
More informationHigh serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism?
European Journal of Endocrinology (1998) 138 141 145 ISSN 0804-4643 High serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism?
More informationSubclinical Hypothyroidism: When to Treat, When to Watch
DOUGLAS S. ROSS, MD Harvard University Subclinical Hypothyroidism: When to Treat, When to Watch Dr Ross is professor of medicine at Harvard Medical School in Boston and a physician at Massachusetts General
More informationThe association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study
European Journal of Endocrinology (2007) 156 181 186 ISSN 0804-4643 CLINICAL STUDY The association between TSH within the reference range and serum lipid concentrations in a population-based study. The
More informationThyroid disease is a common medical problem. The
PERSPECTIVE Should We Be Screening for Thyroid Disease? Gay Canaris, MD, MSPH Thyroid disease is a common medical problem. The prevalence of hyperthyroidism ranges from 0.3% to 1.9%, and the prevalence
More informationSUBCLINICAL HYPOTHYROIDISM (SCH) has been detected
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(10):4860 4866 Printed in U.S.A. Copyright 2001 by The Endocrine Society TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol
More informationThe case for more aggressive screening and treatment of mild thyroid failure
REVIEW ALEJANDRO R. AYALA, MD Staff investigator, Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD LEONARD WARTOFSKY, MD * Chairman,
More informationconcentration in young people.
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Prevalence of antithyroid antibodie concentration in young people. Sekitani, Yui; Hayashida, Naomi; Ka Kozlovsky, Alexander; Yamashita, Sh Clinical
More informationSUBCLINICAL HYPOTHYROIDISM (sht) is a disorder
0021-972X/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(8):3731 3737 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2003-030039 Impaired Endothelium-Dependent
More informationScreening for mild thyroid failure at the periodic health examination: a decision and costeffectiveness
Screening for mild thyroid failure at the periodic health examination: a decision and costeffectiveness analysis Danese M D, Powe N R, Sawin C T, Ladenson P W Record Status This is a critical abstract
More informationHypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002
Hypertriglyceridemia Ara Metjian, M.D. Resident s Report 20 December 2002 Review of Lipids Chylomicrons (CM): Dietary lipids absorbed through the GI tract are assembled intracellularly into CM. Very Low
More informationThe Clinical Consequences and Diagnosis of Hypothyroidism
The Clinical Consequences and Diagnosis of Hypothyroidism VICKY A LEGRYS, KATHERINE HARTMANN, JOAN F WALSH ABBREVIATIONS: CVD = coronary vascular disease; FT 3 = free T 3 ; FT 4 = free T 4 ; T 3 = triiodothyronine;
More informationMeasurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date
MP 2.04.22 Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.193 Lipid Profile as Early Predictor of Complication
More informationHyperthyroidism and hypothyroidism are common
Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Mark Helfand, MD, MPH Background: Subclinical thyroid dysfunction
More informationComparative study of lipid profile between clinical and subclinical hypothyroidism
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20183132 Comparative study
More informationan d in f lu e n c e o f s e ru m T S H on t h e s e ru m t o t al c h o le s t e r ol le v e l
: 62 2 2002 T SH, =A b s t r a c t = P re v ale n c e o f s u b c lin ic al h y p ot h y r oi di s m in h y p e rc h o le s t e r ole m ic a du lt s an d in f lu e n c e o f s e ru m T S H on t h e s e
More informationABSTRACT. Key words: Menopause, Dyslipidemia, Jordan, Thyroid Function. Sireen Shilbayeh, PhD Clinical Pharmacy* Introduction
THE COINCIDENCE OF THYROID GLAND DISORDERS AND DYSLIPIDEMIA DURING A CLIMACTERIC PERIOD: A HOSPITAL-BASED STUDY AT AL-BASHEER AND IBN-ALHYTHAM HOSPITALS Sireen Shilbayeh, PhD Clinical Pharmacy* ABSTRACT
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationORIGINAL INVESTIGATION. that levels of thyrotropin within the reference range are positively and linearly
ORIGINAL INVESTIGATION Thyrotropin Levels and Risk of Fatal Coronary Heart Disease The HUNT Study Bjørn O. Åsvold, MD; Trine Bjøro, MD, PhD; Tom Ivar L. Nilsen, PhD; David Gunnell, MD, PhD; Lars J. Vatten,
More informationPredictive Value of Serum Lipid Ratio and Homocysteine Determination in Hypothyroidism Complicated with Coronary Heart Disease
Science Journal of Public Health 2017; 5(6): 469-473 http://www.sciencepublishinggroup.com/j/sjph doi: 10.11648/j.sjph.20170506.20 ISSN: 2328-7942 (Print); ISSN: 2328-7950 (Online) Predictive Value of
More informationHigh density lipoprotein metabolism
High density lipoprotein metabolism Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic Plasma lipid transport Liver VLDL FC
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationStudy of correlation of TFTs and thyroid antibodies with lipid abnormalities and ECG changes in Hypothyroidism
Original article: Study of correlation of TFTs and thyroid antibodies with lipid abnormalities and ECG changes in Hypothyroidism Dr. Madhulika Mahashabde, Dr. Govind Shiddapur, Dr. Deepti Munjal, Dr. Kashyap
More informationHypothyroidism and Atherosclerosis
0013-7227/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(6):2438 2444 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2003-030398 Hypothyroidism and Atherosclerosis
More informationThyroid Function Is Associated with Presence and Severity of Coronary Atherosclerosis
Clin. Cardiol. 26, 569 573 (2003) Thyroid Function Is Associated with Presence and Severity of Coronary Atherosclerosis J. AUER, M.D., R. BERENT, M.D., T. WEBER, M.D., E. LASSNIG, M.D., B. EBER, M.D.,
More informationA Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
Human Journals Research Article June 2017 Vol.:9, Issue:3 All rights are reserved by Sweety George et al. A Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.
More informationChapter (5) Etiology of Low HDL- Cholesterol
Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the
More informationTHE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS
THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS Hormonal regulation INSULIN lipid synthesis, lipolysis CORTISOL lipolysis GLUCAGON lipolysis GROWTH HORMONE lipolysis CATECHOLAMINES lipolysis LEPTIN catabolism
More informationHYPERTHYROIDISM IS A COMmon
ORIGINAL CONTRIBUTION Thyroid Function and Mortality in Patients Treated for Hyperthyroidism Jayne A. Franklyn, MD, PhD Michael C. Sheppard, PhD, FRCP Patrick Maisonneuve, PhD See also Patient Page. Context
More informationHypertriglyceridemia, Inflammation, & Pregnancy
Hypertriglyceridemia, Inflammation, & Pregnancy Richard L. Nemiroff, MD, FACOG, NLA Professor, Clinical Gynecology Perelman School of Medicine University of Pennsylvania Philadelphia, PA Disclosure of
More informationManagement of Common Thyroid Disorders
Cases Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04,
More informationISSN X (Print) Original Research Article
Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2017; 5(11F):4737-4741 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)
More informationThere are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?
There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,
More informationMastering Thyroid Disorders. Douglas C. Bauer, MD UCSF Division of General Internal Medicine
Mastering Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine Cases 68 yr old female with new atrial fibrillation and no other findings except TSH=0.04, normal free T4 79
More informationManagement of Common Thyroid Disorders
Management of Common Thyroid Disorders Douglas C. Bauer, MD UCSF Division of General Internal Medicine No Disclosures Cases 68 yr old woman with new atrial fibrillation and no other findings except TSH=0.04,
More informationMetabolism and Atherogenic Properties of LDL
Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal
More informationLevels of Homocysteine and Lipid Profile in Subclinical Hypothyroidism
ORIGINALARTICLE Levels of Homocysteine and Lipid Profile in Subclinical Hypothyroidism 1 2 3 4 Aqsa Malik, Amina Rahim, Yasir Iqbal, Abdul Khaliq Naveed ABSTRACT Objective: To measure the serum levels
More informationLIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 4 (53) No. 2-2011 LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV C. DOBRESCU 1 I. MOLEAVIN 1 Abstract:
More informationATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS
LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK
More informationTreatment of Atherosclerosis in 2007
Treatment of Atherosclerosis in 2007 Szilard Voros, M.D. Medical Director Cardiovascular MR and CT Piedmont Hospital, Piedmont Hospital Our Paradigm Genotype Phenotype Environment Atherosclerotic Disease
More informationThyroid Dysfunction Associated with Coronary Heart Disease Barghchi E and Azizi F.
Is Thyroid Dysfunction Associated with Coronary Heart Disease? Elaheh Barghchi 1*, Fereidoun Azizi 2 1 Endocrinologist, Internal Medicine, Department of Endocrinology, University of Medical Sciences, Mashhad,
More informationLipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel
Lipid Metabolism Department of Biochemistry and Molecular Biology II Medical Center Hamburg-ppendorf 1 Lipids. visceral fat. nutritional lipids 0 1.5 3 4.5 9 h. serum lipids. lipid accumulation in the
More informationKatsuyuki Nakajima, PhD. Member of JCCLS International Committee
Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham
More informationThe new guidelines issued in PRESENTATIONS... Future Outlook: Changing Perspectives on Best Practice
... PRESENTATIONS... Future Outlook: Changing Perspectives on Best Practice Based on a presentation by Daniel J. Rader, MD Presentation Summary The guidelines recently released by the National Cholesterol
More informationLipoprotein Pathophysiology. Lipoprotein Pathophysiology
Lipoprotein Pathophysiology Genetic Dyslipidemia Thomas A. Hughes, M.D. Professor of Medicine Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health Science Center GW is a 47
More informationHDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart
Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT
More informationEffect of Subclinical Thyroid Disease on Cardiac Function in Patients on Thyroid Replacement Therapy as Assessed by Radionuclide Ventriculography
Egyptian J. Nucl. Med., Vol. 8, No. 2, December 2013 55 Original Article, Cardiology Effect of Subclinical Thyroid Disease on Cardiac Function in Patients on Thyroid Replacement Therapy as Assessed by
More informationProspective Observation of 5-Year Clinical Course of Subclinical Hypothyroidism in Korean Population
ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism http://dx.doi.org/10.3346/jkms.2013.28.11.1622 J Korean Med Sci 2013; 28: 1622-1626 Prospective Observation of 5-Year Clinical Course of Subclinical
More informationChapter VIII: Dr. Sameh Sarray Hlaoui
Chapter VIII: Dr. Sameh Sarray Hlaoui Lipoproteins a Lipids are insoluble in plasma. In order to be transported they are combined with specific proteins to form lipoproteins: Clusters of proteins and lipids.
More informationANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism
ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism I. Chylomicrons (exogenous pathway) A. 83% triacylglycerol, 2% protein, 8% cholesterol plus cholesterol esters, 7% phospholipid (esp. phosphatidylcholine)
More informationThyroid Hormone and Coronary Artery Disease: From Clinical Correlations to Prognostic Implications
Thyroid Hormone and Coronary Artery Disease: From Clinical Correlations to Prognostic Implications Address for correspondence: Michele Coceani, MD Via Moruzzi 1 56124 Pisa, Italy michecoc@ifc.cnr.it Michele
More informationPLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES
VII, 2013, 2 27, PLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES D. Gavrailova Faculty of Public Health, Medical University So a : (Se).,. Se, - (, )., Se., Se -. :,,, :,, Summary: The essential
More informationLipid Management C. Samuel Ledford, MD Interventional Cardiology Chattanooga Heart Institute
Lipid Management 2018 C. Samuel Ledford, MD Interventional Cardiology Chattanooga Heart Institute Disclosures No Financial Disclosures Disclosures I am an Interventional Cardiologist I put STENTS in for
More informationImplications for Cardiovascular Diseases by Gender Differences in Lipoprotein and Thyroid Hormone Metabolism
Article ID: WMC00670 2046-1690 Implications for Cardiovascular Diseases by Gender Differences in Lipoprotein and Thyroid Hormone Metabolism Corresponding Author: Dr. Simmi Kharb, Professor, Biochemistry,
More informationLipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry
Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different
More informationNature Genetics: doi: /ng.3561
Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8
More informationA study of subclinical hypothyroidism treated with alternate day fixed dose thyroxine therapy
International Journal of Advances in Medicine Jhavar D et al. Int J Adv Med. 2018 Jun;5(3):658-662 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20182119
More informationPlasma Levels of Lipoproteins and Apolipoproteins in Congenital Hypothyroidism: Effects of L-Thyroxine Substitution Therapy
Plasma Levels of Lipoproteins and Apolipoproteins in Congenital Hypothyroidism: Effects of Substitution Therapy Carlo M. Barbagallo, Maurizio R. Averna, Andrea Liotta, Stefania La Grutta, Cristina Maggio,
More informationDisclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017
Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationEvaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism
Annals of Medical Research DOI: 10.5455/annalsmedres.2018.08.154 2019;26(1):32-6 Original Article Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with Andac
More informationPLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL
PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600
More informationWalter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI
Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI Biochemical Analysis (Lipid Panel) Analyte Total Cholesterol Reference Range Patient A < 200 241 LDL-C /= 40 38 Triglycerides
More informationStudy to the effect of Thyroid Dysfunction on Lipid Profile
EUROPEAN ACADEMIC RESEARCH Vol. VI, Issue 2/ May 2018 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Study to the effect of Thyroid Dysfunction on Lipid DHEYAA SH. HAMMAD
More informationORIGINAL INVESTIGATION. Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population
ORIGINAL INVESTIGATION Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population The Health, Aging and Body Composition Study Alka M. Kanaya, MD; Fran Harris,
More informationSCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015
SCREENING FOR THYROID DYSFUNCTION U S P S T F R E C O M M E N D A T I O N S T A T E M E N T M A R I A S T U R L A 8 M A Y 2015 BACKGROUND Thyroid dysfunction represents a continuum from asymptomatic biochemical
More informationPathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More information2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries
Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global
More informationA study of correlation of serum lipid profile in patients with hypothyroidism
Research Article A study of correlation of serum lipid profile in patients with hypothyroidism Janki Pinakin Desai 1, Uday N Vachhani 2, Gaurav Modi 3, Kiran Chauhan 4 1 Department of Biochemistry, GMERS
More informationLipids Testing
Previously Listed as Edit 12 190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol
More informationSubclinical Hypothyroidism and the Alterations of Lipid Profile as a Cardiovascular Risk Factor
Subclinical Hypothyroidism and the Alterations of Lipid Profile as a Cardiovascular Risk Factor Narges Maleki 1, Faranak Kazerouni 1,*, Mehdi Hedayati 2, Ali Rahimipour 1, Mahmoud Parham 3 1 Department
More informationPlacebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN
PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE
More informationCETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia
CETP inhibition: pros and cons Philip Barter The Heart Research Institute Sydney, Australia Philip Barter Disclosures Received honorariums for lectures, consultancies or membership of advisory boards from:
More informationAlteration in Lipid Profile Levels in Women with Subclinical Hypothyroidism
ORIGINAL ARTICLE Alteration in Lipid Profile Levels in Women with Subclinical Hypothyroidism S Ferduosi 1 R Haque 2, N Hoque 3, MM Rahman 4, MH Rahman 1 1 Dept of Biochemistry, Dhaka Medical College, Dhaka;
More informationSubclinical Hypothyroidism Something or Nothing? E. Chester Ridgway University of Colorado SOM August 1-2, 2008
Subclinical Hypothyroidism Something or Nothing? E. Chester Ridgway University of Colorado SOM August 1-2, 2008 Case: A 78 y/o female who is cold with fatigue, dry skin, and poor memory. Free T4 = 1.2
More informationProject Title: Effectiveness of Screening and Treatment of
Project Title: Effectiveness of Screening and Treatment of Subclinical Hypo- or Hyperthyroidism Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 0 Gaither
More informationImplications for Cardiovascular Diseases by Gender Differences in Lipoprotein and Thyroid Hormone Metabolism
Article ID: WMC002127 ISSN 2046-1690 Implications for Cardiovascular Diseases by Gender Differences in Lipoprotein and Thyroid Hormone Metabolism Corresponding Author: Dr. Simmi Kharb, Professor, Biochemistry,
More informationDeficiency of endogenous estrogens has been associated
Menopause Is Associated With Reduced rotection From ostprandial Lipemia André. van Beek, Florianne C. de Ruijter-Heijstek, D. Willem Erkelens, Tjerk W.A. de Bruin Abstract Deficiency of endogenous estrogens
More informationLIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI
LIPID METABOLISM Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI Lipid metabolism is concerned mainly with fatty acids cholesterol Source of fatty acids from dietary fat de novo
More informationNew Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines
Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular
More informationHypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC
Hypertriglyceridemia: Why, When, and How to Treat Gregory Cohn, MD, FNLA, FASPC DISCLOSURES Consultant to Akcea Therapeutics (in the past 12 months). OUTLINE I. Lipoproteins II. Non-HDL-C III. Causes and
More informationDepartment of Pediatrics, Tokai University School of Medicine, Isehara, Kanagawa , Japan
Endocrine Journal 2003, 50 (4), 379 384 Persistence of Mild Hyperthyrotropinemia after Discontinuation of Three-Year Course of Low-Dose L-Thyroxine Therapy in Infants with Borderline Hypothyroidism YUICHIRO
More informationAcetyl CoA HMG CoA Mevalonate (C6) Dimethylallyl Pyrophosphate isopentenyl Pyrophosphate (C5) Geranyl Pyrophosphate (C10) FarnesylPyrophosphate (C15) Squalene (C30) Lanosterol (C30) 7 Dehydrocholesterol
More informationFamilial hypercholesterolaemia in children and adolescents
Familial hypercholesterolaemia in children and adolescents Rationale and recommendations for early identification and treatment European Atherosclerosis Society Consensus Panel Slide deck adapted from:
More informationCLINICAL IMPORTANCE OF LIPOPROTEINS
25 Hyperlipidemias CLINICAL IMPORTANCE OF LIPOPROTEINS Raised levels of low-density lipoprotein (LDL) cholesterol and low levels of high density lipoprotein (HDL) cholesterol are independent risk factor
More informationThe alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism
HORMONES 2007, 6(4):327-333 Research paper The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism Baris Akinci, 1 Abdurrahman Comlekci, 1 Serkan Yener, 1 Tevfik Demir,
More informationStem Cell 2017;8(3) Ahmed Mohammed
The Relation between Hypothyroidism and Dyslipidemia in Non-Diabetic Patients Nabil Abd Elfatah El Kafrawy; Mohamed Abd El Raouf Qorani; Mohamed Zakarya Nouh and Ahmed Shaaban Ahmed Mohammed Internal Medicine,
More informationLipid Metabolism in Familial Hypercholesterolemia
Lipid Metabolism in Familial Hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More information